A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

This study has suspended participant recruitment.
(administrative hold until funding is secured)
Sponsor:
Collaborators:
University of Washington
Fred Hutchinson Cancer Research Center
Information provided by (Responsible Party):
Bastyr University
ClinicalTrials.gov Identifier:
NCT01685489
First received: September 6, 2012
Last updated: April 16, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)